Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma

Modern Pathology

Volumn 24, Issue 9, 2011, Pages 1229-1236

  De Wilde, Roeland F ^a   Ottenhof, Niki A ^a   Jansen, Marnix ^b   Morsink, Folkert H M ^a   De Leng, Wendy W J ^a   Offerhaus, G Johan A ^a,b   Brosens, Lodewijk A A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acinar cell carcinoma; copy number variation; LKB1 STK11; methylation; mTOR; pancreas; Peutz Jeghers syndrome

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; K RAS PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN CTNNB1; PROTEIN KINASE LKB1; PROTEIN P53; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CHROMOSOME 19P; CHROMOSOME 20Q; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

CARCINOMA, ACINAR CELL; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MULTIPLEX POLYMERASE CHAIN REACTION; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

EID: 80052400707     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.83     Document Type: Article

References (33)

1. Morohoshi T, Held G, Klöppel G. Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology 1983;7:645-661. (Pubitemid 13048181)
2. Hoorens A, Lemoine NR, McLellan E, et al Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993;143:685-698. (Pubitemid 24058226)
3. Klimstra DS, Heffess CS, Oertel JE, et al Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992;16: 815-837.
4. Luttges J, Stigge C, Pacena M, et al Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years. Cancer 2004;100:173-182.
5. Webb JN. Acinar cell neoplasms of the exocrine pancreas. J Clin Pathol 1977;30:103-112. (Pubitemid 8037561)
6. Hruban RH, Maitra A, Kern SE, et al Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007;36:831-849 vi.
7. Pellegata NS, Sessa F, Renault B, et al K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-1560. (Pubitemid 24106422)
8. Terhune PG, Heffess CS, Longnecker DS. Only wildtype c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog 1994; 10:110-114. (Pubitemid 24246965)
9. Terhune PG, Memoli VA, Longnecker DS. Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice. Pancreas 1998;16: 6-12. (Pubitemid 28034423)
10. Abraham SC, Wu TT, Hruban RH, et al Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002;160:953-962. (Pubitemid 34224584)
11. Moore PS, Orlandini S, Zamboni G, et al Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 2001;84:253-262. (Pubitemid 32113454)
12. Rigaud G, Moore PS, Zamboni G, et al Allelotype of pancreatic acinar cell carcinoma. Int J Cancer 2000;88:772-777.
13. Klumpen HJ, Queiroz KC, Spek CA, et al mTOR inhibitor treatment of pancreatic cancer in a patient with Peutz-Jeghers syndrome. J Clin Oncol 2011;29:e150-e153.
14. Jansen M, Ten Klooster JP, Offerhaus GJ, et al LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev 2009;89:777-798.
15. Giardiello FM, Brensinger JD, Tersmette AC, et al Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-1453. (Pubitemid 32198669)
16. Giardiello FM, Welsh SB, Hamilton SR, et al Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-1514. (Pubitemid 17076235)
17. Sato N, Rosty C, Jansen M, et al STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillarymucinous neoplasms of the pancreas. Am J Pathol 2001;159:2017-2022. (Pubitemid 33104257)
18. Canto MI, Goggins M, Hruban RH, et al Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-781; quiz 665. (Pubitemid 43825802)
19. Yee NS, Furth EE, Pack M. Clinicopathologic and molecular features of pancreatic adenocarcinoma associated with Peutz-Jeghers syndrome. Cancer Biol Ther 2003;2:38-47.
20. Su GH, Hruban RH, Bansal RK, et al Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-1840. (Pubitemid 29262866)
21. de Leng WW, Jansen M, Carvalho R, et al Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet 2007;72:568-573. (Pubitemid 350131065)
22. Boland CR, Thibodeau SN, Hamilton SR, et al A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257. (Pubitemid 28521189)
23. Langeveld D, van Hattem WA, de Leng WW, et al SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clin Cancer Res 2010;16:4126-4134.
24. Taruscio D, Paradisi S, Zamboni G, et al Pancreatic acinar carcinoma shows a distinct pattern of chromosomal imbalances by comparative genomic hybridization. Genes Chromosomes Cancer 2000;28:294-299. (Pubitemid 30399559)
25. Shackelford DB, Vasquez DS, Corbeil J, et al mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci USA 2009;106:11137-11142.
26. Robinson J, Lai C, Martin A, et al Oral rapamycin reduces tumour burden and vascularization in Lkb1 mice. J Pathol 2009;219:35-40.
27. Wei C, Amos CI, Zhang N, et al Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model. Cancer Lett 2009;277:149-154.
28. Zhang N, Lyons S, Lim E, et al A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging. Clin Cancer Res 2009;15:4915-4924.
29. Jiao Y, Shi C, Edil BH, et al DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011;331:1199-1203.
30. Hezel AF, Gurumurthy S, Granot Z, et al Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 2008;28:2414-2425. (Pubitemid 351429985)
31. Habbe N, Shi G, Meguid RA, et al Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci USA 2008;105: 18913-18918.
32. DiGiuseppe JA, Redston MS, Yeo CJ, et al p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995;147:884-888.
33. Sato N, Ueki T, Fukushima N, et al Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002;123:365-372. (Pubitemid 34747556)